Literature DB >> 16682927

Metabolic treatment of critically ill patients: energy balance and substrate disposal.

G Iapichino1, D Radrizzani, S Armani, A Noto, P Spanu, G Mistraletti.   

Abstract

Oxidation of substrates is the main biochemical process used by the human body to produce energy. Different substrates (carbohydrates, lipids, and proteins) have different effects on oxygen consumption and carbon dioxide production: during the critical phase of pathologies it could be relevant pay attention to the use of various nutrients, that have some altered effect respect to the normal subjects metabolism, and during the length of metabolic treatment, too. Generally, nutrition lead to replenish body stores, while endogenous substrates are used to be oxidized. Critically ill patients show a preference for prompt energy availability (i.e. glucose) to avoid endogenous protein catabolism; lipids are shown to have a more pronounced storage effect. Adequate amount of energy intake in carbohydrates determine an increase of RQ, that means a shift from a more lipid-based to a more glucose-based oxidation. Composition of dietary intake can be usefully different for each pathology, and also for different periods of the same pathology, because critically ill patients have a variety of metabolic needs during their stay in ICU.

Entities:  

Mesh:

Year:  2006        PMID: 16682927

Source DB:  PubMed          Journal:  Minerva Anestesiol        ISSN: 0375-9393            Impact factor:   3.051


  2 in total

1.  Beneficial effects of combination therapy of intradialytic parenteral nutrition and oral L-carnitine administration.

Authors:  Masataka Tsunoda; Ryota Ikee; Naomi Sasaki; Nobuo Hashimoto
Journal:  Int Urol Nephrol       Date:  2012-09-11       Impact factor: 2.370

2.  Characters of Nutrition Status and Energy-delivery Patterns of the University-based Surgical Intensive Care Units in Thailand (Multi-center THAI-SICU Study).

Authors:  Supakrit Auiwattanakul; Kaweesak Chittawatanarat; Onuma Chaiwat; Sunthiti Morakul; Suneerat Kongsayreepong; Winai Ungpinitpong; Surakrant Yutthakasemsunt; Supawan Buranapin
Journal:  Med Arch       Date:  2018-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.